SCHEMBL7670709

SCHEMBL7670709

Cc1cccc(C(=O)Nc2ccc(S(=O)(=O)NCC(=O)O)cc2)c1

nearest known ligand 0.74

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GPR17 Q13304 1/20 0.66
TP53 P04637 2/20 0.62
MEN1 O00255 2/20 0.62
KMT2A Q03164 2/20 0.62
FFAR1 O14842 1/20 0.62
GLA P06280 1/20 0.62
LMNA P02545 2/20 0.60
NPC1 O15118 1/20 0.58
RAB9A P51151 1/20 0.58
MAPT P10636 1/20 0.57
KCNK3 O14649 2/20 0.55
KCNK9 Q9NPC2 2/20 0.55
KCNH2 Q12809 1/20 0.55
POLB P06746 1/20 0.54
NT5E P21589 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
KAT6A Q92794 1/20 0.53
ALDH1A1 P00352 1/20 0.53
IDO1 P14902 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7673888 0.86 LMNA (0.57) MEN1KMT2ALMNAPOLBALDH1A1
SCHEMBL4834530 0.86 LMNA (0.74) MEN1KMT2ALMNASMN1; SMN2ALDH1A1
SCHEMBL7670533 0.85 MAPT (0.66) GPR17TP53MEN1KMT2ALMNA
SCHEMBL7665938 0.85 MEN1 (0.66) MEN1KMT2ALMNANPC1RAB9A
SCHEMBL7670604 0.85 LMNA (0.56) GPR17MEN1KMT2ALMNAALDH1A1
SCHEMBL7668838 0.85 LMNA (0.68) TP53MEN1KMT2ALMNANPC1
SCHEMBL5099330 0.85 MEN1 (0.62) MEN1KMT2ALMNANPC1RAB9A
SCHEMBL7671404 0.84 GPR17 (0.59) GPR17TP53MEN1KMT2AFFAR1
SCHEMBL4825269 0.82 MEN1 (0.68) GPR17MEN1KMT2ALMNANPC1
SCHEMBL14534186 0.82 MMP1 (0.71) MEN1KMT2ALMNAMAPTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6403644-B1 FOR PREVENTION AND/OR TREATMENT OF DISEASES INDUCED BY OVEREXPRESSION AND EXCESS ACTIVITY OF MATRIX METALLOPROTEINASE; FOR EXAMPLE, RHEUMATOID, ARTHROSTEITIS, UNUSUAL BONE RESORPTION, OSTEOPOROSIS, PERIODONTITIS ONO PHARMACEUTICAL CO., LTD. (JP) 2002-06-11 US claimed
US-6403644-B1 FOR PREVENTION AND/OR TREATMENT OF DISEASES INDUCED BY OVEREXPRESSION AND EXCESS ACTIVITY OF MATRIX METALLOPROTEINASE; FOR EXAMPLE, RHEUMATOID, ARTHROSTEITIS, UNUSUAL BONE RESORPTION, OSTEOPOROSIS, PERIODONTITIS ONO PHARMACEUTICAL CO., LTD. (JP) 2002-06-11 US disclosed
US-6177466-B1 Sulfonylamino acid derivatives ONO PHARMACEUTICAL CO., LTD. (JP) 2001-01-23 US disclosed
EP-0757037-A2 Sulfonylamino acid derivatives as metalloproteinase inhibitors ONO PHARMACEUTICAL CO., LTD. (JP) 1997-02-05 EP disclosed